Real Time Screeners Intraday Screeners now on Real Time Data (Updated every 5 mins)
Stock Listing : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 

Stock Analysis of Glenmark Pharmaceuticals , Birds-Eye-view On Returns/Technicals/Funda/F&O

About Strength Screener

Charts Of Glenmark Pharmaceuticals Ltd.

1D   1W   2W   1M   3M   1Y   2Y   5Y   
Interactive Charts

Price / Volume Action

CodeGLENMARK
EOD Share Price213.05
Previous Share Price203.85
Price Change 9.20
Change % 4.51%
Volume4511.92 K
Five Day Avg Vol2420.72 K
Beta0.989465
Fno StockYes, F&O list
Last Business Date03-Apr-20

Price Gain/Loss

DurationAbsolute ChgChg %
One Week 13.90 6.98
Two Weeks 1.35 0.638
One Month -69.25 -24.53
Three Months -139.05 -39.49
Six Months -106.50 -33.33
One Year -428.30 -66.78

Highs / Lows

DurationHighLow
One Week219.5190.0
Two Weeks219.5184.45
One Month294.9161.65
Three Months365.2161.65
Six Months374.0161.65
One Year659.3161.65

Key Moving Average

MA SMAEMA
5 Days 203.53205.663
15 Days 203.023212.933
20 Days 216.965221.051
50 Days 275.92260.715
100 Days 308.547297.101
200 Days 345.801355.409
Detailed MA Analysis of GLENMARK ...

Key Technical Indicators

MACD -22.11
RSI 51.46
RSI (Smooth) 41.95
ADX 38.66
Chaikin Money Flow -0.138
Williams %R -52.77
PSAR 166.91
Detailed Tech Analysis GLENMARK ...

Financial Data Highlights

Market Cap5757.58
Book Value/ Share209.032
Enterprise Value1310.44
Revenue TTM10436.95
Gross Profit TTM6362.44
Revenue /Share TTM369.87
Consensus Target663.61
Key Financial Highlights GLENMARK ...

Financial Ratios of GLENMARK

EPS25.42
PE8.02
Div/Share2.00
Div Yield0.970
Trailing PE8.02
Forward PE5.49
Price/Book0.975
Key Financial Ratios of GLENMARK ...

Key Profit & Loss Data

Period31_Mar_2019Growth
Net Inc 891.67 15.17 %
Ops Income1217.27 3.65 %
Revenue9865.47 8.72 %
Ops Expense8648.20 10.72 %
PBT1257.98 17.92 %
Gross Profit6503.13 9.28 %
Div Paid-67.88 0 %
Key P&L GLENMARK ...

Futures of GLENMARK

Closing Price213.00
Premium/Discount -0.050
Price Change 8.55
Change % 4.18
Future OI2497.60 K
OI Change % 3.00
Future Contracts2234.00
Contracts Change 41.12
Lot Size1400

Put / Call Options

Call Max Traded Strike Price220.00
Call Max Traded SP Contracts202
Call Option Open Interest280.00 K
Call Option OI Chg % 76.99
Put Max Traded Strike Price200.00
Put Max Traded SP Contracts10
Put Option Open Interest49.00 K
Put Option OI Chg % 20.69
Option Chain With Impled Vol & Greeks ...

Put Call Ratio - 30/04/2020

Put Open Interest49.00 K
Call Open Interest280.00 K
PCR Open Interest0.175
PCR OI ReadingStrong Bullish
Put Contracts Traded20.00
Call Contracts Traded497.00
PCR Volume0.0402
PCR Vol ReadingStrong Bullish
Put Call Ratio GLENMARK ...

Price Range (PR) /Volatility

PeriodAvg PR Range %
LBD PR23.7011.12
Week PR29.5013.85
Month PR23.7011.12
5 Day Period14.367.32
10 Day Period16.768.72
5 Week Period57.0232.94
3 Months Period73.2244.51
Price Range /Volatility GLENMARK ...

Highlights & Chart Patterns of Glenmark Pharmaceuticals Ltd.

Share has hit Two Week high on 03-Apr-20.
Stock has jumped by more than 10% in last two weeks from its lowest level of 184.45 dt 23-Mar-20
Stock has jumped by more than 15% in last One Month from its lowest level of 161.65 dt 13-Mar-20.
Stock has jumped by more than 25% in last three Month from its lowest level of 161.65 dt 13-Mar-20.
Stock has fallen by more than 15% in last One Month from its highest level of 294.9 dt 05-Mar-20.
Stock has fallen by more than 25% in last three Month from its highest level of 365.2 dt 17-Jan-20.
Bullish engulfing Candlestick pattern was formed by Glenmark Pharmaceuticals Ltd. on 03/04/2020 with rise in volume. Prior to pattern formation this share was in uptrend.
More Chart Patterns Glenmark Pharmaceuticals Ltd. ...
You can now customize Equity with technical , SMA , Fin Data, chart patterns in one Page. Click here to view guide

Share Price History of Glenmark Pharmaceuticals Ltd.

Date Open High Low Close Volume
03-Apr-20 201.55 219.50 195.80 213.05 4511 K
01-Apr-20 206.10 213.70 200.50 203.85 2367 K
31-Mar-20 199.00 208.00 197.00 205.85 1545 K
30-Mar-20 197.00 199.55 190.00 195.75 1365 K
27-Mar-20 210.75 216.20 197.05 199.15 2312 K
26-Mar-20 195.00 216.35 192.00 208.20 2970 K
25-Mar-20 190.00 196.80 187.35 191.55 1812 K
24-Mar-20 204.00 204.95 188.00 190.60 2270 K
23-Mar-20 196.00 207.95 184.45 188.10 1570 K
20-Mar-20 207.25 218.85 204.10 211.70 4262 K
About Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited, together with its subsidiaries, develops, manufactures, and markets pharmaceutical products in India, North America, Latin America, Europe, and internationally. The company provides branded and generic formulations in therapeutic areas of dermatology, respiratory, and oncology; and various active pharmaceutical ingredients. Its product pipeline includes GBR 830, which is in Phase 2b clinical trails for the treatment of atopic dermatitis; GRC 27864 that is in Phase 2b clinical trails for the treatment of osteoarthritic pain; and GRC 17536, which has completed Phase 2a clinical trails for the treatment of painful diabetic neuropathy. The company's products pipeline comprises GBR 1302, which is in Phase 1a/1b clinical trails for the treatment of breast cancer; and GBR 1342 that is in Phase 1a/1b clinical trails for the oncology; GRC 5xxxx, a MAP4K1 inhibitor compound, which is in pre-clinical studies for the treatment of cancer; and Ryaltris for allergic rhinitis. The company was founded in 1977 and is based in Mumbai, India.
About Strength

Strength is based on Deep Analysis, Back Testing and Historical Trend Analysis using Machine Learning. Overall Technical Strength is based on 50+ indicators including Technicals, moving Avg, chart patterns, candlestick and proprietary algorithms.Technical Strength is currently calculated around around 5 to 6 PM. This is an automated process and in NO WAY should be considered as a tip as its based on past data. We strongly recommend to use these signals for information only and seek advise from a certified professional for any trading decision.If you like it then please share. The more the visitors the more the innovations. Feedback

We are working on fundamental strength also. Please share your views to help shape up the requirement.

( Intraday Analysis is on Real Time Data (Updated every 5 Mins). All Other analysis is based on End of Trade day's Value. Expected time of update is between 5 to 5.30 PM exchange time Zone)


All Rights Reserved By Mintnovate Market Research Pvt Ltd.